Reaction
Post-Traumatic Neck Syndrome reporting signals
As of the last recalculation, Post-Traumatic Neck Syndrome appears in 803 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is BOTULINUM TOXIN TYPE A (PRR 97.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Botulinum Toxin Type A | 44 | 97.1 | 97.5 |
| Sumatriptan Succinate | 45 | 48.8 | 48.9 |
| Lithium | 44 | 47.8 | 47.9 |
| Lithium Bromatum | 44 | 47.8 | 47.9 |
| Temazepam | 46 | 33.5 | 33.5 |
| Cyclobenzaprine | 58 | 32.4 | 32.4 |
| Sumatriptan | 32 | 22.6 | 22.6 |
| Erenumab-Aooe | 44 | 21.8 | 21.9 |
| Fulvestrant | 24 | 19.4 | 19.4 |
| Onabotulinumtoxina | 40 | 14.1 | 14.1 |
| Diclofenac Potassium | 5 | 12.1 | 12.1 |
| Sodium Oxybate | 27 | 11.0 | 11.0 |
| Diclofenac Potassium, Film Coated | 3 | 9.3 | 9.3 |
| Diclofenac Potassium Tablets | 3 | 9.3 | 9.3 |
| Naltrexone Hydrochloride And Bupropion Hydrochloride | 3 | 9.2 | 9.2 |
| Eptinezumab-Jjmr | 3 | 8.6 | 8.6 |
| Galcanezumab-Gnlm | 4 | 3.3 | 3.3 |